Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

BACKGROUND: Over the past years, EGFR tyrosine kinase inhibitors (TKI) revolutionized treatment response. 1st-generation (reversible) EGFR TKI and later the 2nd –generation irreversible EGFR TKI Afatinib were aimed to improve treatment response. Nevertheless, diverse resistance mechanisms develop wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagener-Ryczek, Svenja, Heydt, Carina, Süptitz, Juliane, Michels, Sebastian, Falk, Markus, Alidousty, Christina, Fassunke, Jana, Ihle, Michaela Angelika, Tiemann, Markus, Heukamp, Lukas, Wolf, Jürgen, Büttner, Reinhard, Merkelbach-Bruse, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216404/
https://www.ncbi.nlm.nih.gov/pubmed/32397977
http://dx.doi.org/10.1186/s12885-020-06920-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216404/
https://www.ncbi.nlm.nih.gov/pubmed/32397977
http://dx.doi.org/10.1186/s12885-020-06920-3

Ejemplares similares